These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5773406)

  • 1. [The effect of intraoperative massive dose therapy on the postoperative condition].
    Schmidt D
    Wien Med Wochenschr; 1969 Jan; 119(1):15-8. PubMed ID: 5773406
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide effect on changes in rabbit peripheral blood in the development period.
    Maślińska D; Swierczyńska A; Koch I
    Acta Physiol Pol; 1983; 34(1):85-90. PubMed ID: 6637534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The potentials of intraoperative radiation therapy in improving the surgical results in tumors of the gastrointestinal tract].
    Berdov BA; Mardynskiĭ IuS; Skoropad VIu; Titova LN
    Vopr Onkol; 1995; 41(2):94-6. PubMed ID: 7483457
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclophosphamide--attack dose or continuous therapy].
    Müller U
    Zentralbl Gynakol; 1971 Oct; 93(40):1369-75. PubMed ID: 5126440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
    Kiene J; Sezer O; Rasche H; Klempa I
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():244-6. PubMed ID: 9101844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support.
    Bozzetti F; Gianotti L; Braga M; Di Carlo V; Mariani L
    Clin Nutr; 2007 Dec; 26(6):698-709. PubMed ID: 17683831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gastrointestinal stromal tumors (GIST)--current concepts of surgical management].
    Hohenberger P; Reichardt P; Gebauer B; Wardelmann E
    Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1817-20. PubMed ID: 15314746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal experiment studies on the possibility of therapy and prevention of liver metastases in gastrointestinal carcinoma].
    Altenbrunn HJ; Andrysek O; Steenbeck L; Wildner GP
    Nucl Med (Stuttg); 1965; 2():287-92. PubMed ID: 5888957
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of intraoperative cytostatic high dosage therapy in the treatment of cancer. I].
    Kirsch R; Schmidt D; Fichler J
    Zentralbl Chir; 1967 Sep; 92(38):2559-70 contd. PubMed ID: 5595511
    [No Abstract]   [Full Text] [Related]  

  • 11. [Follow-up of the CEA in gastrointestinal neoplasms after surgical intervention].
    Piantino P; Garrone C; Cattaneo U; Bonardi O; Toppino M; Pecchio F
    Minerva Dietol Gastroenterol; 1981; 27(4):541-5. PubMed ID: 7335225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Operative limits in geriatrics according to a new method of calculating risk rate].
    Harada M; Shinbata O; Hara T; Nakajima T; Takeuchi S
    Shujutsu; 1966 Oct; 20(10):834-44. PubMed ID: 5978606
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
    Zuluaga AF; Salazar BE; Rodriguez CA; Zapata AX; Agudelo M; Vesga O
    BMC Infect Dis; 2006 Mar; 6():55. PubMed ID: 16545113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of large doses of cytostatic preparations in surgery in connection with cancer to prevent relapses and metastasis].
    Kirsch R; Schmidt D
    Eksp Khir Anesteziol; 1968; 13(2):49-53. PubMed ID: 5670769
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of perioperative hyperalimentation on complications in patients with carcinoma and weight loss.
    Holter AR; Fischer JE
    J Surg Res; 1977 Jul; 23(1):31-4. PubMed ID: 406484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of the degree of risk after radical operations for gastrointestinal tract cancer].
    Bernshteĭn MI; Simonov NN; Frid IA
    Anesteziol Reanimatol; 1980; (2):23-6. PubMed ID: 7386930
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research in surgery--an example of gastroenterology surgery].
    Schreiber HW; Winkler R
    Chirurg; 1983 Apr; 54(4):186-8. PubMed ID: 6851740
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
    Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
    Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patient age as a reason for refusing radical surgery for tumors of the gastrointestinal tract].
    Bernshteĭn MI; Berezkin DP; Evtiukhin AI; Ekimov VI; Mel'nikov RA
    Vestn Khir Im I I Grek; 1980 May; 124(5):41-4. PubMed ID: 7423760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.